Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea
· Delayed Price · Currency is KRW 4,780.00
-80.00 (-1.65%)
At close: Mar 26, 2025, 3:30 PM KST
Korea Arlico Pharm Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 190,436 | 187,155 | 167,737 | 140,157 | 124,809 | Upgrade
|
| Other Revenue | - | - | - | -0 | 0 | Upgrade
|
| Revenue | 190,436 | 187,155 | 167,737 | 140,157 | 124,809 | Upgrade
|
| Revenue Growth (YoY) | 1.75% | 11.58% | 19.68% | 12.30% | 7.79% | Upgrade
|
| Cost of Revenue | 90,708 | 77,038 | 60,871 | 52,672 | 45,134 | Upgrade
|
| Gross Profit | 99,728 | 110,116 | 106,866 | 87,485 | 79,674 | Upgrade
|
| Selling, General & Admin | 97,378 | 101,455 | 89,043 | 73,629 | 65,039 | Upgrade
|
| Research & Development | 4,539 | 4,180 | 6,532 | 8,194 | 3,142 | Upgrade
|
| Other Operating Expenses | 354.96 | 211.67 | 285.4 | 180.17 | 389.1 | Upgrade
|
| Operating Expenses | 104,887 | 107,044 | 97,002 | 82,691 | 69,075 | Upgrade
|
| Operating Income | -5,159 | 3,073 | 9,864 | 4,794 | 10,599 | Upgrade
|
| Interest Expense | -2,105 | -1,587 | -968.39 | -276.95 | -639.09 | Upgrade
|
| Interest & Investment Income | 338.53 | 435.17 | 518.13 | 167.72 | 361.15 | Upgrade
|
| Currency Exchange Gain (Loss) | 236.79 | 36.71 | 141.57 | 138.03 | -74.76 | Upgrade
|
| Other Non Operating Income (Expenses) | -192 | 1,319 | -1,019 | -213.08 | -344.92 | Upgrade
|
| EBT Excluding Unusual Items | -6,881 | 3,276 | 8,536 | 4,610 | 9,902 | Upgrade
|
| Gain (Loss) on Sale of Investments | 240.36 | 190.04 | 168.93 | 30.37 | 24.67 | Upgrade
|
| Gain (Loss) on Sale of Assets | 392.92 | 9.08 | -313.88 | 964.68 | -198.54 | Upgrade
|
| Other Unusual Items | 73.26 | - | - | - | - | Upgrade
|
| Pretax Income | -6,174 | 3,476 | 8,391 | 5,605 | 9,728 | Upgrade
|
| Income Tax Expense | -816.11 | 414.67 | 356.96 | 675.18 | 1,356 | Upgrade
|
| Net Income | -5,358 | 3,061 | 8,034 | 4,930 | 8,372 | Upgrade
|
| Net Income to Common | -5,358 | 3,061 | 8,034 | 4,930 | 8,372 | Upgrade
|
| Net Income Growth | - | -61.90% | 62.98% | -41.12% | -16.54% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 29 | 16 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | -49.01% | 79.54% | 8.74% | -0.06% | 51.13% | Upgrade
|
| EPS (Basic) | -357.00 | 204.00 | 535.14 | 327.00 | 555.00 | Upgrade
|
| EPS (Diluted) | -357.00 | 104.00 | 532.00 | 327.00 | 555.00 | Upgrade
|
| EPS Growth | - | -80.45% | 62.69% | -41.08% | -44.78% | Upgrade
|
| Free Cash Flow | -12,085 | -16,237 | -14,137 | 3,699 | -4,843 | Upgrade
|
| Free Cash Flow Per Share | -805.18 | -551.67 | -862.39 | 245.38 | -321.05 | Upgrade
|
| Gross Margin | 52.37% | 58.84% | 63.71% | 62.42% | 63.84% | Upgrade
|
| Operating Margin | -2.71% | 1.64% | 5.88% | 3.42% | 8.49% | Upgrade
|
| Profit Margin | -2.81% | 1.64% | 4.79% | 3.52% | 6.71% | Upgrade
|
| Free Cash Flow Margin | -6.35% | -8.68% | -8.43% | 2.64% | -3.88% | Upgrade
|
| EBITDA | 1,456 | 7,844 | 12,977 | 7,400 | 12,629 | Upgrade
|
| EBITDA Margin | 0.77% | 4.19% | 7.74% | 5.28% | 10.12% | Upgrade
|
| D&A For EBITDA | 6,615 | 4,772 | 3,113 | 2,606 | 2,030 | Upgrade
|
| EBIT | -5,159 | 3,073 | 9,864 | 4,794 | 10,599 | Upgrade
|
| EBIT Margin | -2.71% | 1.64% | 5.88% | 3.42% | 8.49% | Upgrade
|
| Effective Tax Rate | - | 11.93% | 4.25% | 12.05% | 13.94% | Upgrade
|
| Advertising Expenses | 1,096 | 890.82 | 294.4 | 590.9 | 141.32 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.